Actively Recruiting
Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2025-09-09
40
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the MiA-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD). Through the use of the Mio-Training, cognitive development will be strengthened and metacognitive thinking and awareness will increase. The MiA-Study is conducted additionally to the Mio-study to evaluate the effectiveness of the Mio-Training specifically within the ADHD population. The Mio-Training for children and adolescence with ADHD includes a combination of cognitive and coordinative training tasks and prospective as well as retrospective metacognitive questions. In a randomized controlled trial, the Mio-Training will be analysed for its efficacy on metacognitive thinking and executive functions. In particular, the investigators are interested in factors that affect the efficacy of the training program such as compliance, age, sex or the severity of the ADHD. This study will give insight into the role of metacognition in cognitive performance and will foster the development of children and adolescents with ADHD in the long-term.
CONDITIONS
Official Title
Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Informed consent signed by participant and/or parent/legal guardian
- Age between 8 and 16 years
- Diagnosis of ADHD (mild, moderate, or severe)
- Intelligence score above 85 (WISC-V short form)
- German or French speaking
- Willingness to complete study assessments without ADHD medication
You will not qualify if you...
- Presence of unstable neurological conditions (e.g., epilepsy) that significantly impair development
- Severe psychiatric disorders (e.g., eating disorders) or severe learning disabilities that impair development
- Known or suspected non-compliance with study procedures
- Inability to follow study procedures due to language problems
- Investigator or their family members, employees, or other dependent persons enrolled in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Insespital, University Hospital Bern
Bern, Switzerland, 3010
Actively Recruiting
Research Team
R
Regula Everts, Prof. Dr. phil.
CONTACT
S
Saskia Salzmann, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here